A sensitive colorimetric procedure has been developed for the assay of angiotensin converting enzyme (EC 3.4.15.1) in serum. Serum (10 L) is incubated for 30 mm with hippurylglycyl-glycine as described earlier (C/in Chem 28: [1352][1353][1354][1355] 1982). After a Folin-Wu deproteinization, the liberated glycyl-glycine is derivatized with a borate-buffered (pH 9.3) trinitrobenzenesulfonate solution (60 mmol/L) to form trinitrophenyl-glycylglycine, the absorbance of which is read at 420 nm vs a serum blank. The linear range extends to an activity of more than 900 U/L of serum and the detection limit is <4 U/L. The mean activity for serum from 50 blood bank donors and 25 patients with active sarcoidosis was 281 (SD 77) and 693 (SD 81) U/L, respectively. The method demonstrates good precision (CVs <2.8%) and correlates well (r = .99) with results from a "high-pressure" liquid chromatographic procedure for determining hippuricacid.In addition, the proposed method is widely applicable, involving only commonly available apparatus.
counter (3, 4), "high-pressure" liquid chromatography equipment (8) , or a fluorometer (9, 10). These disadvantages preclude widespread use and limit the clinical applications of ACE determinations. Here we describe a new assay system for ACE, involving only stable and inexpensive reagents and a photometer; it can thus be successfully applied in every clinical laboratory.
The sensitivity of the assay is such that only 10 .tL of serum will provide reliable and accurate results.
Materials and Methods

Materials
Serum samples:
Blood was sampled from blood-bank donors, ages 18-65 years. The blood was allowed to clot, centrifuged within 2 h, and the serum was stored at -25 #{176}C.
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Samples were assayed forenzyme activity within a month after collection.
Reagents:
Hippuryl-glycyl-glycine (Hip-Gly-Gly) was purchased from Bachem Feinchemikalien, Bubendorf, The procedure can be interrupted between deproteinization and arylation for longer intervals (up to at least three days). After addition of the TNBS solution, however, the absorbance must be read within 3 h. One unit (U) ofACE activity isdefinedas the amount of enzyme requiredto release1 mol of hippuricacid per minute per liter of serum.
If a wavelength other than 420 nm isused (forwavelength interval, see Figure   1 ), a calibration curve can be prepared with a Gly-Gly standard solution as follows. Dissolve 52.9 mg of Gly-Gly in 10 mL of water (40 mmol/L). Dilute this solution, which contains 0.4 mol of Gly-Gly per 10 L, to the following concentrations: 0.2, 0.1, 0.08, 0.06, 0.04, and 0.02 .tmolI10 pL. These quantities correspond to the Gly-Gly produced after 30 mm by 10 iL of serum containing 1333, 667, 333, 267, 200, 133, and 67 U of ACE per liter. Use these solutions in place of serum in the previously described procedure, read the absorbance against distilled water, and calculate a calibration line as a regression between the absorbance and the activity. 
Results and Discussion
Development and Evaluation of the Method
Using a previously developed incubation procedure (8), we have obtained an enzymic activity 10-fold greater than that with the currently popular method of Lieberman (2). This rate ofhydrolysis was sufficient to allow the quantification of the split dipeptide by a simple derivatization procedure. Although l-fluoro-2,4-dimtrobenzene is frequently used to derivatize amino acids and peptides (11), we preferred to use TNBS, which reacts in milder conditions and, unlike the dinitro derivative (12), does not react with alcohols, sugars, and lipids.
Deproteinization:
Because TNBS reacts with proteins as well as amino acids (13), we could not use a one-step approach but had to deproteinize the incubation mixture. Sulfosalicylic acid, trichloroacetic acid, and perchloric acid were evaluated as deproteinizing reagents, but their supernates were not completely clear after centrifugation. 
The final pH of the reaction mixture (9.3) is critical, because lower values slow the reaction and higher values decrease the stability of TNP-Gly-Gly.
Because TNBS hydrolyzes to picric acid (13, 16) in alkaline conditions, we evaluated this reaction by using parallelaccess spectrophotometry.
First-order kinetics (k = 2.1 x i0 min'; 37 #{176}C) was observed, resulting in a loss of TNBS at a rate of about 10%/h (initial concentration 1.67 mmollL). This reaction is responsible for the slowly increasing sample and blank readings. Because we used relatively low TNBS concentrations, the net absorbance was not affected, as shown in Figure 2 . Thus it is not necessary to quench the formation of picric acid, as some previous investigators have done (13, 16) .
Calibration.
The calibration curve (see Procedure, and Figure 3 ) had a correlation coefficient of0.99,whilethe CV forthe readings varied between 1.4and 2.0%. The molar absorptivity forTNP-Gly-Gly (15650 L . mol' . cm') did not alter when the Gly-Gly was added either to a HEPES salt buffer without substrateor to a deproteinized serum-conmining blank. Mean SD
Within-day
Between-day n = 10 each.
CV, %
pmol GIy-QIy.min.L1 1333 ACE u/L serum Fig. 3 . Calibration line as a regression between ACE activity and the absorbance of TNP-Gly-Gly TNP-GIy-GIy was formedin the presence and absence of deproteinuzed serum; absorbances were read against the serum blank or a reagent blank; points are mean ± SD of 10 samples
Linearities.
That the linearrange extends to an ACE activity of more than 900 UIL ofserum was demonstrated with an unusually high pathological serum sample (more than the mean serum activity + 2 SD of 25 patients with active sarcoidosis), which showed a straight-line dilution curve ( Figure 4 ) and an activity of 945 U/L. This sample consumed less than 9% of the substrate during the 30-mm incubation time, an indication that substrate depletion will not occur with this method. Figure 2 shows a plot of color yield vs time for both a normal serum and a pathological serum. The TNBS consumption during incubation with a serum having 500 U of ACE activity per liter, including an approximation for the serum blank consumption, is <4%.
Sensitivity.
With the procedure described we are able to detect ACE as low as 4 U/L of serum. Using a twofold concentrated derivatization procedure leads to detection of less than 2 U/L of serum. Table 2 shows results of within-day and between-day precision studies for both a normal and an abovenormal serum; pipetting was done with a dispenser. A within-day precision study, with manual pipetting of the same sera, had respective CVs of 2.4 and 2.1% (n = 2 x 10).
Precision.
Correlation.
Resultsobtained by the derivatization technique (y) and those obtained with an assay based on "highpressure" liquid chromatography of hippuric acid (8) on the same serum specimens, but different incubation mixtures, were correlated by least-squares linear-regression analysis: y = 0.99x + 3.6, r = .99 (n = 50). A least-squares linearregression analysis of data obtained when the two methods were used to assay the same incubation mixtures gave y = 0.95x + 4.8, r = .99 (n = 39).
Sample preservation. Decreases in ACE activity under various conditions of serum preservation are moderate ( Figure 5 ). Storage at -25 #{176}C until assay seems to be preferred. A control serum stored at -25 #{176}C showed a CV of 4.5% (mean 202 U/L, n = 48) when assayed monthly for a year.
Reference interval. For samplesfrom 50 blood bank donors (25 men, 25 women, ages 18-65 years), the mean ACE activity was 281 (SD 77) U/L.
Clinical Applications of Serum ACE
Sera from 25 untreated patients with active sarcoidosis had increasedACE activity, ranging from 575 to 945 U/L (mean 693,SD 81 U/L).Other studies have confirmedthat increasedclinical activity of sarcoidosis (2, 17-19) or the need for therapy of sarcoidosis with steroids (1), may be reflected by high ACE activity. The highest ACE activity was found in patients with severe parenchymal lung infiltration due to sarcoidosis, activities being lowest in patients with inactive disease or after successful treatment with steroids (1). Recent reports (20) have also focused attention on the correlation between serum ACE and the 67Ga scan in detecting and monitoring sarcoidosis. Interest in these noninvasive procedures is growing, given the other procedures for investigation of sarcoidosis, such as biopsy, the KveimSiltzbach skin test, and serum lysozyme activity. A biopsy sample may fail to be from an involved site, and granulomas are not necessarily diagnosticof sarcoidosis (20 23) . Increased ACE activities are also found in some patients with viral hepatitis and liver cirrhosis, probably originating from an altered pulmonary circulation (24-26). Patients suffering from diabetes mellitus, especially when associated with microangiopathy and retinopathy, may also show increased ACE activity (27) , as do patients with silicosis and asbestosis (28, 29), leprosy (30), or Gaucher's disease (18, 31, 32) . In Gaucher's disease, ACE activity is also increased in the spleen (32). Another condition with increased ACE activity is hypoxia, which can occur in idiopathic respiratory distress syndrome of the newborn (33).
ACE activities are not significantly increased and may even be decreased in four other granulomatous conditions: Crohn's disease, primary biliary cirrhosis, Hodgkin's disease, and active tuberculosis 
